FINWIRES · TerminalLIVE
FINWIRES

$MIRM

7 stories mentioning MIRMUpdated just now

Every FINWIRES story that references MIRM, newest first.

Insider Trading

Mirum Pharmaceuticals Insider Sold Shares Worth $4,000,000, According to a Recent SEC Filing

Jolanda Howe, Senior Vice President, Global Controller, on August 18, 2026, sold 40,000 shares in Mirum Pharmaceuticals (MIRM) for $4,000,000. Following the Form 4 filing with the SEC, Howe has control over a total of 1,274 common shares of the company, with 1,274 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1759425/000197420026000012/xslF345X05/form4-08192026_100826.xml

$MIRM
Insider Trading

Mirum Pharmaceuticals Insider Sold Shares Worth $1,978,402, According to a Recent SEC Filing

Christopher Peetz, Director, CEO, on August 10, 2026, sold 20,000 shares in Mirum Pharmaceuticals (MIRM) for $1,978,402. Following the Form 4 filing with the SEC, Peetz has control over a total of 381,809 common shares of the company, with 194,309 shares held directly and 187,500 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1759425/000161474026000012/xslF345X05/form4-08112026_090838.xml

$MIRM
Insider Trading

Mirum Pharmaceuticals Insider Sold Shares Worth $2,445,382, According to a Recent SEC Filing

Christopher Peetz, Director, CEO, on July 06, 2026, sold 20,000 shares in Mirum Pharmaceuticals (MIRM) for $2,445,382. Following the Form 4 filing with the SEC, Peetz has control over a total of 381,809 common shares of the company, with 194,309 shares held directly and 187,500 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1759425/000161474026000011/xslF345X05/form4-07082026_090744.xml

$MIRM
Insider Trading

Mirum Pharmaceuticals Insider Sold Shares Worth $611,273, According to a Recent SEC Filing

Eric Bjerkholt, CFO, on July 06, 2026, sold 5,000 shares in Mirum Pharmaceuticals (MIRM) for $611,273. Following the Form 4 filing with the SEC, Bjerkholt has control over a total of 42,181 common shares of the company, with 42,181 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1759425/000119735026000008/xslF345X05/form4-07082026_090727.xml

$MIRM
Insider Trading

Mirum Pharmaceuticals Insider Sold Shares Worth $2,875,103, According to a Recent SEC Filing

Christopher Peetz, Director, Chief Executive Officer, on June 01, 2026, sold 30,000 shares in Mirum Pharmaceuticals (MIRM) for $2,875,103. Following the Form 4 filing with the SEC, Peetz has control over a total of 381,809 common shares of the company, with 194,309 shares held directly and 187,500 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1759425/000161474026000010/xslF345X05/form4-06022026_070609.xml

$MIRM
Research

Wolfe Research Initiates Mirum Pharmaceuticals With Outperform Rating

Mirum Pharmaceuticals (MIRM) has an average rating of Buy and mean price target of $146.58, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$MIRM
Wire

RBC Capital Adjusts Mirum Pharmaceuticals Price Target to $142 From $128, Maintains Outperform Rating

Mirum Pharmaceuticals (MIRM) has an average rating of Buy and mean price target of $146.36, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $103.03, Change: $-7.05, Percent Change: -6.40%

$MIRM

Track with the FINWIRES app suite

FolioX
FolioX
Track MIRM in your portfolio
WheelAI
WheelAI
Analyze MIRM options with the wheel strategy
StockInsider
StockInsider
See market sentiment on MIRM